Seeing Is Believing
Currently out of the existing stock ratings of Robbie Marcus, 161 are a BUY (63.64%), 77 are a HOLD (30.43%), 15 are a SELL (5.93%).
Analyst Robbie Marcus, carries an average stock price target met ratio of 61.55% that have a potential upside of 19.21% achieved within 141 days. Previously, Robbie Marcus worked at JPMORGAN.
Robbie Marcus’s has documented 478 price targets and ratings displayed on 36 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on NPCE, Neuropace at 14-May-2025.
Analyst best performing recommendations are on CVRX (CVRX).
The best stock recommendation documented was for INGN (INOGEN) at 5/8/2019. The price target of $72 was fulfilled within 1 day with a profit of $4.21 (6.21%) receiving and performance score of 62.1.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$0.74
$0.52 (236.36%)
$1
1 years 9 months 30 days ago
(08-Aug-2023)
5/8 (62.5%)
$0.1 (15.63%)
61
Hold
$1.5
$1.28 (581.82%)
2 years 9 months 22 days ago
(16-Aug-2022)
1/2 (50%)
$0.05 (3.45%)
2
Buy
$1.5
$1.28 (581.82%)
2 years 11 months 14 days ago
(24-Jun-2022)
1/5 (20%)
$0.96 (177.78%)
27
Sell
$19
3 years 6 months 26 days ago
(12-Nov-2021)
0/2 (0%)
$3.71 (16.84%)
Hold
$23
$21.36 (1302.44%)
$30
4 years 2 months 19 days ago
(19-Mar-2021)
0/3 (0%)
$4.37 (22.18%)
Which stock is Robbie Marcus is most bullish on?
Which stock is Robbie Marcus is most reserved on?
What Year was the first public recommendation made by Robbie Marcus?